Therapeutic Agents Triggering Nonapoptotic Cancer Cell Death
Citations Over TimeTop 10% of 2013 papers
Abstract
It is widely recognized that the evasion of apoptotic cell death is one of the hallmarks of cancer. For many years cytotoxic agents have been developed to target apoptotic cell death as a main method of treating cancer. However, the occurrence of cellular defects involving the apoptotic machinery in many cancers has resulted in an acquired resistance to apoptotic cell death, undermining the effectiveness of chemotherapeutic agents. Over the past decade, research has revealed a growing number of cell death pathways that are not dependent on apoptosis. In addition, compounds specifically triggering these alternative cell death pathways have been identified and explored as novel cancer treatment options. These novel anticancer agents are critically discussed by the authors, and therefore, the current Perspective represents a resource for a practicing medicinal chemist looking for new opportunities to combat cancers resistant to the established proapoptotic therapeutic agents.
Related Papers
- Apoptosis of human pancreatic cancer cells induced by Triptolide(2008)
- Relationships between induction of apoptosis by CDDP in Scaber cell and apoptosis-related proteins(2003)
- [Apoptosis and cytostatic agents].(1992)
- 자궁경부 상피내종양 및 자궁경부암 조직에서 bcl-2 및 c-myc 암유전자 발현과 세포증식 및 apoptosis와의 상관관계에 관한 연구(1998)
- Identification of specific genes and pathways involved in NSAIDs-induced apoptosis of human colon cancer cells(2006)